Metabolic profiling in disease diagnosis, toxicology and personalized healthcare

Current Pharmaceutical Biotechnology

Volumn 12, Issue 7, 2011, Pages 976-995

  Kamleh, M Anas ^a   Spagou, Konstantina ^a   Want, Elizabeth J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Biomarker; Diagnostic; Mass spectrometry; Metabolic profiling; Metabonomics; Multivariate; NMR spectroscopy; Statistics; Toxicology

Indexed keywords

ALLANTOIN; AMITRIPTYLINE; ARIPIPRAZOLE; BIOLOGICAL MARKER; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DIOSCOREA BULIFERA EXTRACT; HEAVY METAL; HERBACEOUS AGENT; HYPOXANTHINE; IBUPROFEN; INDOMETACIN; INOSINE; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; PARACETAMOL; PLACEBO; PLANT EXTRACT; RISPERIDONE; ROSIGLITAZONE; TACROLIMUS; TUMOR MARKER; UNCLASSIFIED DRUG; XANTHINE; XIAOYAOSAN;

ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SAFETY; GRAFT REJECTION; GYNECOLOGIC DISEASE; HEALTH CARE; HEALTH CARE PERSONNEL; HEART DISEASE; HEART INFARCTION; HEAVY METAL POISONING; HERBAL MEDICINE; HUMAN; INFECTION; INFORMATION PROCESSING; LIVER TOXICITY; LUNG DISEASE; MASS SPECTROMETRY; MENTAL DISEASE; METABOLIC DISORDER; METABOLIC PROFILING; METABOLOMICS; NEPHROTOXICITY; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITION; SCHIZOPHRENIA; STOMACH DISEASE; TOXICOLOGY;

BIOLOGICAL MARKERS; DIAGNOSIS, COMPUTER-ASSISTED; DRUG TOXICITY; HUMANS; INDIVIDUALIZED MEDICINE; METABOLIC DISEASES;

EID: 79959349608     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111795909069     Document Type: Article

References (179)

1. Nicholson, J. K.; Lindon, J. C. Systems biology: Metabonomics. Nature, 2008, 455, 1054-1056.
2. Fiehn, O.; Kopka, J.; Dormann, P.; Altmann, T.; Trethewey, R. N.; Willmitzer, L. Metabolite profiling for plant functional genomics. Nat. Biotechnol., 2000, 18 (11), 1157-1161.
3. Fiehn, O. Metabolomics--the link between genotypes and pheno-types. Plant Mol. Biol., 2002, 48, (1-2), 155-171.
4. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysi-ological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 1999, 29, (11), 1181-1189.
5. Want, E. J.; Wilson, I. D.; Gika, H.; Theodoridis, G.; Plumb, R. S.; Shockcor, J.; Holmes, E.; Nicholson, J. K. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc., 2010, 5 (6), 1005-1018.
6. Want, E. J.; O'Maille, G.; Smith, C. A.; Brandon, T. R.; Urit-boonthai, W.; Qin, C.; Trauger, S. A.; Siuzdak, G. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal. Chem., 2006, 78(3), 743-752.
7. Beckonert, O.; Keun, H. C.; Ebbels, T. M.; Bundy, J.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc., 2007, 2 (11), 2692-2703.
8. Bollard, M. E.; Stanley, E. G.; Lindon, J. C.; Nicholson, J. K.; Holmes, E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed., 2005, 18(3), 143-162.
9. Lenz, E. M.; Wilson, I. D. Analytical strategies in metabonomics. J. Proteome. Res., 2007, 6(2), 443-58.
10. Villas-Boas, S. G.; Hojer-Pedersen, J.; Akesson, M.; Smedsgaard, J.; Nielsen, J. Global metabolite analysis of yeast: evaluation of sample preparation methods. Yeast 2005, 22, 1155-1169.
11. Ippolito, J. E.; Xu, J.; Jain, S.; Moulder, K.; Mennerick, S.; Crow-ley, J. R.; Townsend, R. R.; Gordon, J. I. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc.Natl. Acad. Sci. USA, 2005, 102, (28), 9901-9906.
12. Beckonert, O.; Coen, M.; Keun, H. C.; Wang, Y.; Ebbels, T. M. D.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat. Protocol., (6), 1019-1032.
13. Masson, P.; Alves, A. C.; Ebbels, T. M. D.; Nicholson, J. K.; Want, E. J. Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS. Analyt. Chem., 2010, 82(18),7779-7786.
14. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Metabonomics techniques and applications to pharmaceutical research & development. Pharm. Res., 2006, 23(6), 1075-1088.
15. Dettmer, K.; Aronov, P. A.; Hammock, B. D. Mass spectrometry-based metabolomics. Mass. Spectrom. Rev., 2007, 26(1), 51-78.
16. Coen, M.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem. Res. Toxicol., 2008, 21 (1), 9-27.
17. Lindon, J. C.; Holmes, E.; Bollard, M. E.; Stanley, E. G.; Nicholson, J. K. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers, 2004, 9 (1), 1-31.
18. Want, E. J.; Cravatt, B. F.; Siuzdak, G. The expanding role of mass spectrometry in metabolite profiling and characterization. ChemBioChem, 2005, 6(11), 1941-1951.
19. Theodoridis, G.; Gika, H. G.; Wilson, I. D. LC-MS-based methodology for global metabolite profiling in metabonomics/ metabolom-ics. Trac-Trends Analyt. Chem., 2008, 27(3), 251-260.
20. Bell, J. D.; Sadler, P. J.; Morris, V. C.; Levander, O. A. Effect of aging and diet on proton NMR spectra of rat urine. Magn. Reson. Med., 1991, 17(2), 414-422.
21. Bollard, M. E.; Holmes, E.; Lindon, J. C.; Mitchell, S. C.; Branstet-ter, D.; Zhang, W.; Nicholson, J. K. Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. Anal. Biochem., 2001, 295(2), 194-202.
22. Moolenaar, S. H.; Engelke, U. F.; Wevers, R. A. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann. Clin. Biochem., 2003, 40(Pt 1), 16-24.
23. Brindle, J. T.; Antti, H.; Holmes, E.; Tranter, G.; Nicholson, J. K.; Bethell, H. W.; Clarke, S.; Schofield, P. M.; McKilligin, E.; Mose-dale, D. E.; Grainger, D. J. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med., 2002, 8(12), 1439-1444.
24. Barton, S. J.; Howe, F. A.; Tomlins, A. M.; Cudlip, S. A.; Nicholson, J. K.; Bell, B. A.; Griffiths, J. R. Comparison of in vivo 1H MRS of human brain tumours with 1H HR-MAS spectroscopy of intact biopsy samples in vitro. MAGMA, 1999, 8 (2), 121-128.
25. Toye, A. A.; Dumas, M. E.; Blancher, C.; Rothwell, A. R.; Fearn-side, J. F.; Wilder, S. P.; Bihoreau, M. T.; Cloarec, O.; Azzouzi, I.; Young, S.; Barton, R. H.; Holmes, E.; McCarthy, M. I.; Tatoud, R.; Nicholson, J. K.; Scott, J.; Gauguier, D. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia, 2007, 50(9), 1867-1879.
26. Yap, I. K.; Clayton, T. A.; Tang, H.; Everett, J. R.; Hanton, G.; Provost, J. P.; Le Net, J. L.; Charuel, C.; Lindon, J. C.; Nicholson, J. K. An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate. J. Proteome Res., 2006, 5(10), 2675-2684.
27. Bollard, M. E.; Keun, H. C.; Beckonert, O.; Ebbels, T. M.; Antti, H.; Nicholls, A. W.; Shockcor, J. P.; Cantor, G. H.; Stevens, G.; Lindon, J. C.; Holmes, E.; Nicholson, J. K. Comparative me-tabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol. Appl. Pharmacol., 2005, 204 (2), 135-151.
28. Lindon, J. C.; Nicholson, J. K.; Holmes, E.; Antti, H.; Bollard, M. E.; Keun, H.; Beckonert, O.; Ebbels, T. M.; Reily, M. D.; Robertson, D.; Stevens, G. J.; Luke, P.; Breau, A. P.; Cantor, G. H.; Bible, R. H.; Niederhauser, U.; Senn, H.; Schlotterbeck, G.; Sidelmann, U. G.; Laursen, S. M.; Tymiak, A.; Car, B. D.; Lehman-McKeeman, L.; Colet, J. M.; Loukaci, A.; Thomas, C. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol., 2003, 187 (3), 137-146.
29. Keun, H. C. Metabonomic modeling of drug toxicity. Pharmacol. Ther., 2006, 109(1-2), 92-106.
30. Gerhard, U.; Thomas, S.; Mortishire-Smith, R. Accelerated metabolite identification by extraction-NMR. J. Pharm. Biomed. Anal., 2003, 32(3), 531-538.
31. Griffin, J. L.; Bonney, S. A.; Mann, C.; Hebbachi, A. M.; Gibbons, G. F.; Nicholson, J. K.; Shoulders, C. C.; Scott, J. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol Genom., 2004, 17(2), 140-149.
32. Keun, H. C.; Beckonert, O.; Griffin, J. L.; Richter, C.; Moskau, D.; Lindon, J. C.; Nicholson, J. K. Cryogenic probe 13C NMR spec-troscopy of urine for metabonomic studies. Anal. Chem., 2002, 74(17), 4588-4593.
33. Cheng, L. L.; Lean, C. L.; Bogdanova, A.; Wright, S. C. Jr.; Ack-erman, J. L.; Brady, T. J.; Garrido, L. Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn. Reson. Med., 1996, 36(5), 653-658.
34. Garrod, S.; Humpfer, E.; Spraul, M.; Connor, S. C.; Polley, S.; Connelly, J.; Lindon, J. C.; Nicholson, J. K.; Holmes, E. High-resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla. Magn. Reson. Med., 1999, 41(6), 1108-1118.
35. Moka, D.; Vorreuther, R.; Schicha, H.; Spraul, M.; Humpfer, E.; Lipinski, M.; Foxall, P. J.; Nicholson, J. K.; Lindon, J. C. Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectros-copy. J. Pharm. Biomed. Anal., 1998, 17(1), 125-132.
36. Taylor, J. L.; Wu, C. L.; Cory, D.; Gonzalez, R. G.; Bielecki, A.; Cheng, L. L. High-resolution magic angle spinning proton NMR analysis of human prostate tissue with slow spinning rates. Magn. Reson. Med., 2003, 50(3), 627-632.
37. Coen, M.; Hong, Y. S.; Clayton, T. A.; Rohde, C. M.; Pearce, J. T.; Reily, M. D.; Robertson, D. G.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. The mechanism of galactosamine toxicity revisited; a metabonomic study. J. Proteome. Res., 2007, 6(7), 2711-2719.
38. Waters, N. J.; Waterfield, C. J.; Farrant, R. D.; Holmes, E.; Nicholson, J. K. Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis. J. Pro-teome. Res., 2006, 5(6), 1448-1459.
39. Bollard, M. E.; Garrod, S.; Holmes, E.; Lindon, J. C.; Humpfer, E.; Spraul, M.; Nicholson, J. K. High-resolution (1)H and (1)H-(13)C magic angle spinning NMR spectroscopy of rat liver. Magn. Reson. Med., 2000, 44(2), 201-207.
40. Keun, H. C.; Ebbels, T. M.; Antti, H.; Bollard, M. E.; Beckonert, O.; Schlotterbeck, G.; Senn, H.; Niederhauser, U.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. Chem. Res. Toxicol., 2002, 15(11), 1380-1386.
41. Lenz, E.; Wilson, I. Analytical strategies in metabonomics. J. Pro-teome Res., 2007, 6(2), 443-458.
42. Dettmer, K.; Aronov, P.; Hammock, B. Mass spectrometry-based metabolomics. Mass. Spectrom. Rev., 2007, 26, 51-78.
43. Want, E. J.; Coen, M.; Masson, P.; Keun, H. C.; Pearce, J. T.; Reily, M. D.; Robertson, D. G.; Rohde, C. M.; Holmes, E.; Lindon, J. C.; Plumb, R. S.; Nicholson, J. K. Ultra performance liquid chromatography-mass spectrometry profiling of bile acid metabolites in biofluids: application to experimental toxicology studies. Anal. Chem., 2010, 82(12), 5282-5289.
44. Wilson, I. D.; Plumb, R.; Granger, J.; Major, H.; Williams, R.; Lenz, E. M. HPLC-MS-based methods for the study of me-tabonomics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2005, 817 (1), 67-76.
45. Kopka, J.; Schauer, N.; Krueger, S.; Birkemeyer, C.; Usadel, B.; Bergmüller, E.; Dörmann, P.; Weckwerth, W.; Gibon, Y.; Stitt, M.; Willmitzer, L.; Fernie, A.R.; Steinhauser, D. GMD@CSB.DB: the golm metabolome database. Bioinformatics, 2005, 21 (8), 1635-1638.
46. Sangster, T.; Major, H.; Plumb, R.; Wilson, A. J.; Wilson, I. D. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst, 2006, 131(10), 1075-8.
47. Kanani, H.; Chrysanthopoulos, P. K.; Klapa, M. I. Standardizing GC-MS metabolomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2008, 871 (2), 191-201.
48. Jonsson, P.; Gullberg, J.; Nordstrom, A.; Kusano, M.; Kowalczyk, M.; Sjostrom, M.; Moritz, T. A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal. Chem., 2004, 76 (6), 1738-1745.
49. Shellie, R. A.; Welthagen, W.; Zrostlikova, J.; Spranger, J.; Ristow, M.; Fiehn, O.; Zimmermann, R. Statistical methods for comparing comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry results: metabolomic analysis of mouse tissue extracts. J. Chromatogr. A, 2005, 1086 (1-2), 83-90.
50. Kanani, H. H.; Klapa, M. I. Data correction strategy for me-tabolomics analysis using gas chromatography-mass spectrometry. Metab. Eng., 2007, 9 (1), 39-51.
51. Soga, T.; Imaizumi, M. Capillary electrophoresis method for the analysis of inorganic anions, organic acids, amino acids, nucleo-tides, carbohydrates and other anionic compounds. Electrophoresis, 2001,22 (16), 3418-3425.
52. Ramautar, R.; Somsen, G. W.; de Jong, G. J. Direct sample injection for capillary electrophoretic determination of organic acids in cerebrospinal fluid. Anal. Bioanal. Chem., 2007, 387 (1), 293-301.
53. Ullsten, S.; Danielsson, R.; Backstrom, D.; Sjoberg, P.; Bergquist, J. Urine profiling using capillary electrophoresis-mass spectrome-try and multivariate data analysis. J. Chromatogr. A, 2006, 1117 (1), 87-93.
54. Soga, T.; Ohashi, Y.; Ueno, Y.; Naraoka, H.; Tomita, M.; Nishi-oka, T. Quantitative metabolome analysis using capillary electro-phoresis mass spectrometry. J. Proteome Res., 2003, 2 (5), 488-494.
55. Idborg-Bjorkman, H.; Edlund, P. O.; Kvalheim, O. M.; Schuppe-Koistinen, I.; Jacobsson, S. P. Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis. Anal Chem., 2003, 75(18), 4784-4792.
56. Plumb, R. S.; Stumpf, C. L.; Granger, J. H.; Castro-Perez, J.; Haselden, J. N.; Dear, G. J. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Commun. Mass Spectrom., 2003, 17(23), 2632-8.
57. Cubbon, S.; Antonio, C.; Wilson, J.; Thomas-Oates, J. Me-tabolomic applications of HILIC-LC-MS. Mass Spectrom. Rev., 2009, 29(5),671-684.
58. Spagou, K.; Tsoukali, H.; Raikos, N.; Gika, H.; Wilson, I. D.; Theodoridis, G. Hydrophilic interaction chromatography coupled to MS for metabonomic/metabolomic studies. J. Separ. Sci., 2010, 33(6-7), 716-727.
59. Tolstikov, V. V.; Fiehn, O. Analysis of highly polar compounds of plant origin: combination of hydrophilic interaction chromatogra-phy and electrospray ion trap mass spectrometry. Anal. Biochem., 2002,301(2), 298-307.
60. Idborg, H.; Zamani, L.; Edlund, P. O.; Schuppe-Koistinen, I.; Ja-cobsson, S. P. Metabolic fingerprinting of rat urine by LC/MS Part 1. Analysis by hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B Ana-lyt. Technol. Biomed. Life. Sci., 2005, 828, (1-2), 9-13.
61. Gika, H. G.; Theodoridis, G. A.; Wilson, I. D. Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine. J. Sep. Sci., 2008, 31(9), 1598-1608.
62. Wilson, I. D.; Nicholson, J. K.; Castro-Perez, J.; Granger, J. H.; Johnson, K. A.; Smith, B. W.; Plumb, R. S. High resolution ultra performance liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res., 2005, 4, (2), 591-598.
63. Gika, H. G.; Theodoridis, G. A.; Wingate, J. E.; Wilson, I. D. Within-day reproducibility of an HPLC-MS-based method for me-tabonomic analysis: application to human urine. J. Proteome Res., 2007,6(8), 3291-303.
64. Katajamaa, M.; Oresic, M. Processing methods for differential analysis of LC/MS profile data. BMC Bioinformatics, 2005, 6, 179.
65. Dieterle, F.; Ross, A.; Schlotterbeck, G.; Senn, H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonom-ics. Anal. Chem., 2006, 78 (13), 4281-4290.
66. Smith, C. A.; Want, E. J.; O'Maille, G.; Abagyan, R.; Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem., 2006, 78(3), 779-787.
67. Katajamaa, M.; Miettinen, J.; Oresic, M. MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics, 2006, 22 (5), 634-636.
68. Barker, M.; Rayens, W. Partial least squares for discrimination. J. Chemometrics, 2003, 17(3), 166-173.
69. Bylesjo, M.; Rantalainen, M.; Cloarec, O. OPLS discriminant analysis: Combining the strengths of PLS-DA and SIMCA classification. J. Chemometrics, 2006, 20 (8-10), 341-351.
70. Trygg, J.; Wold, S. Orthogonal projections to latent structures (O-PLS). J. Chemometrics, 2002, 16 (3), 119-128.
71. Trygg, J. O2-PLS for qualitative and quantitative analysis in multi-variate calibration. J. Chemometrics, 2002, 16(6), 283-293.
72. Barker, M.; Rayens, W. Partial least squares for discrimination. J. Chemometrics, 2003, 17(3), 166-173.
73. Brereton, R. G. Consequences of sample sizes, variable selection, model validation and optimisation for predicting classification ability from analytical data. Trends Analyt. Chem., 2006, 25, 1103-1111.
74. Nicholson, J. K.; Foxall, P. J.; Spraul, M.; Farrant, R. D.; Lindon, J. C. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem., 1995, 67(5), 793-811.
75. Cloarec, O.; Dumas, M. E.; Craig, A.; Barton, R. H.; Trygg, J.; Hudson, J.; Blancher, C.; Gauguier, D.; Lindon, J. C.; Holmes, E.; Nicholson, J. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal. Chem., 2005, 77(5), 1282-9.
76. Cloarec, O.; Campbell, A.; Tseng, L. H.; Braumann, U.; Spraul, M.; Scarfe, G.; Weaver, R.; Nicholson, J. K. Virtual chroma-tographic resolution enhancement in cryoflow LC-NMR experiments via statistical total correlation spectroscopy. Anal. Chem., 2007, 79 (9), 3304-3311.
77. Crockford, D. J.; Lindon, J. C.; Cloarec, O.; Plumb, R. S.; Bruce, S. J.; Zirah, S.; Rainville, P.; Stumpf, C. L.; Johnson, K.; Holmes, E.; Nicholson, J. K. Statistical search space reduction and two-dimensional data display approaches for UPLC-MS in biomarker discovery and pathway analysis. Anal. Chem., 2006, 78 (13), 4398-408.
78. Coen, M.; Hong, Y. S.; Cloarec, O.; Rhode, C. M.; Reily, M. D.; Robertson, D. G.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Het-eronuclear 1H-31P statistical total correlation NMR spectroscopy of intact liver for metabolic biomarker assignment: application to galactosamine-induced hepatotoxicity. Anal. Chem., 2007, 79(23), 8956-8966.
79. Hanagiri, T.; Baba, T.; So, T.; Yasuda, M.; Sugaya, M.; Ono, K.; So, T.; Uramoto, H.; Takenoyama, M.; Yasumoto, K. Time trends of surgical outcome in patients with non-small cell lung cancer. J. Thoracic. Oncol., 2010, 5 (6), 825-829
80. Lorena Urbanelli; Alessandro Magini; Virginia Ciccarone; Francesco Trivelli; Mario Polidoro; Brunella Tancini; Emiliani, C. New perspectives for the diagnosis of alzheimer's disease. Recent Patents CNS Drug Discov., 2009, 4 (3), 160-181
81. Dag, A.; Martin Wilhelm, K. The epidemiology of dementia associated with Parkinson disease. J. Brain Pathol., 2010, 20(3),633-639
82. D. Galasso; A. Carnuccio; Larghi, A. Pancreatic cancer: diagnosis and endoscopic staging. Eur. Rev. Med. Pharmacol. Sci., 2010, 14(4), 375-385.
83. Shiro, U.; Wei, Z.; Kindra, B.; Vladimir, T. Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun. Mass Spectrom., 2010, 24(5), 613-620.
84. Giske A, deg Ãrd, G. F.; Grinde, M. T.; Sitter, B.; Axelson, D. E.; Lundgren, S.; Fjãsne, H. E.; Dahl, S.; Gribbestad, I. S.; Bathen, T. F. Multivariate Modeling and prediction of breast cancer prognostic factors using MR metabolomics. J. Proteome Res., 2009, 9(2), 972-979.
85. Wu, H.; Xue, R.; Lu, C.; Deng, C.; Liu, T.; Zeng, H.; Wang, Q.; Shen, X. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J. Chroma-togr. B, 2009, 877(27), 3111-3117.
86. Kunle, O.; Robert, M. W.; Christine, B. A.; Alan, H.; Susan, E. M.; Jonathan, T.; John, P. G.; Gregory, M.; Thomas, S.; William, C.; Feng, Q.; Bernadette, K.; Marilyn, I.; Shashikant, L.; James, L. A. Detection of epithelial ovarian cancer using 1H-NMR-based me-tabonomics. Intl. J. Cancer, 2005, 113(5), 782-788.
87. Baker, D. L.; Morrison, P.; Miller, B.; Riely, C. A.; Tolley, B.; Westermann, A. M.; Bonfrer, J. M. G.; Bais, E.; Moolenaar, W. H.; Tigyi, G. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA, 2002, 287(23), 3081-3082.
88. Guan, W.; Zhou, M.; Hampton, C.; Benigno, B.; Walker, L. D.; Gray, A.; McDonald, J.; Fernandez, F. Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines. BMC Bioinformatics, 2009, 10 (1), 259.
89. Hirayama, A.; Kami, K.; Sugimoto, M.; Sugawara, M.; Toki, N.; Onozuka, H.; Kinoshita, T.; Saito, N.; Ochiai, A.; Tomita, M.; Esumi, H.; Soga, T. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res., 2009, 69 (11), 4918-4925.
90. Daniel, M.; José Manuel, M.; Antonio, B.; Jose Antonio, L.; Carlos, V.; Bernardo, C. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed., 2009, 22(3), 342-348.
91. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 2009, 457(7231), 910-914.
92. Gowda, G. A. N. Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers. Biomarkers Med., 4(2), 299-314.
93. Chen, J.; Wang, W.; Lv, S.; Yin, P.; Zhao, X.; Lu, X.; Zhang, F.; Xu, G. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal. Chimica Acta, 2009, 650 (1), 3-9.
94. Fan, T.; Lane, A.; Higashi, R.; Farag, M.; Gao, H.; Bousamra, M.; Miller, D. Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM). Mol. Cancer, 2009, 8 (1), 41.
95. Buist, A. S.; McBurnie, M. A.; Vollmer, W. M.; Gillespie, S.; Burney, P.; Mannino, D. M.; Menezes, A. M. B.; Sullivan, S. D.; Lee, T. A.; Weiss, K. B.; Jensen, R. L.; Marks, G. B.; Gulsvik, A.; Nizankowska-Mogilnicka, E. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet, 2007, 370 (9589), 741-750.
96. Carraro, S.; Rezzi, S.; Reniero, F.; Heberger, K.; Giordano, G.; Zanconato, S.; Guillou, C.; Baraldi, E. Metabolomics applied to exhaled breath condensate in childhood asthma. Am. J. Respir. Crit. Care Med., 2007, 175, 986-990.
97. Francis, L. D.; Ellen, S.; William, H. M.; Prabhakar, B.; Joshua, J. M.; John, C. M. Organ donation and utilization in the United States, 2004. Am. J. Transplant., 2005, 5 (4p2), 862-873.
98. Foxall, P. J. D.; Mellotte, G. J.; Bending, M. R.; Lindon, J. C.; Nicholson, J. K. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int., 1993, 43(1), 234-245.
99. Duarte, I. F.; Stanley, E. G.; Holmes, E.; Lindon, J. C.; Gil, A. M.; Tang, H.; Ferdinand, R.; McKee, C. G.; Nicholson, J. K.; Vilca-Melendez, H.; Heaton, N.; Murphy, G. M. Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal. Chem., 2005, 77 (17), 5570-5578.
100. Serkova, N. J.; Zhang, Y.; Coatney, J. L.; Hunter, L.; Wachs, M. E.; Niemann, C. U.; Mandell, M. S. Early detection of graft failure using the blood metabolic profile of a liver recipient. Transplantation, 2007, 83 (4), 517-521
101. Zhang, J.; Yan, L.; Chen, W.; Lin, L.; Song, X.; Yan, X.; Hang, W.; Huang, B. Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Anal. Chimica Acta, 2009, 650 (1), 16-22.
102. Ignasi, B.; Gustavo de, L.; Eva, M.; Antonio, C.; Santiago, A.; Jaume, C.-R.; José, A. B.; David, G.-D. Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Mag. Reson. Med., 2008, 60 (1), 27-32.
103. World Health, O. ICD-10: international statistical classification of diseases and related health problems/World Health Organization. World Health Organization: Geneva:, 2004.
104. Ince, J.; McNally, A. Development of rapid, automated diagnostics for infectious disease: advances and challenges. Exp. Rev. Med. Devices, 2009, 6 (6), 641-651.
105. Himmelreich, U.; Malik, R.; Kãhn, T.; Daniel, H.-M.; Somorjai, R. L.; Dolenko, B.; Sorrell, T. C. Rapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host response. PLoS One, 2009, 4 (4), e5328.
106. Alexandra, J. S.; Mark, R. V.; Alexandra, K. B.; Michael, A. B.; Elizabeth, A. W.; Paul, M. S.; Saaeha, R.; Stephen, P. Y. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases - a diagnostic tool? NMR Biomed., 2010, 23(2), 123-132.
107. Widiger, T. A.; Sankis, L. M. Adult psychopathology: issues and controversies. Annu. Rev. Psychol, 2000, 51(1), 377-404.
108. McGrath, J.; Saha, S.; Welham, J.; El Saadi, O; MacCauley, C; Chant, D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med., 2004, 2(1), 13.
109. Prabakaran, S.; Swatton, J. E.; Ryan, M. M.; Huffaker, S. J.; Huang, J.-J.; Griffin, J. L.; Wayland, M.; Freeman, T.; Dudbridge, F.; Lilley, K. S.; Karp, N. A.; Hester, S.; Tkachev, D.; Mimmack, M. L.; Yolken, R. H.; Webster, M. J.; Torrey, E. F.; Bahn, S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry, 2004, 9(7), 684-697.
110. Yao, J. K.; Dougherty, G. G. Jr.; Reddy, R. D.; Keshavan, M. S.; Montrose, D. M.; Matson, W. R.; Rozen, S.; Krishnan, R. R.; McEvoy, J.; Kaddurah-Daouk, R. Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol. Psychiatry, 2009, 15(9),938-953
111. Lisa, A. P.; Matthew, W. M.; Krishnan, K. R. R.; Rima, K.-D.; David, C. S. A preliminary metabolomic analysis of older adults with and without depression. Intl. J. Geriatric Psychiatry, 2007, 22 (5), 418-423.
112. Hayman, R.; Brockelsby, J.; Kenny, L.; Baker, P. Preeclampsia: The endothelium, circulating factor(s) and vascular endothelial growth factor. J. Soc. Gynecol Investig., 1999, 6 (1), 3-10.
113. Kenny, L. C; Broadhurst, D.; Brown, M.; Dunn, W. B.; Redman, C. W. G.; Kell, D. B.; Baker, P. N. Detection and identification of novel metabolomic biomarkers in preeclampsia. Reprod. Sci., 2008, 15 (6), 591-597.
114. Dunn, W. B.; Broadhurst, D.; Brown, M.; Baker, P. N; Redman, C. W.; Kenny, L. C; Kell, D. B. Metabolic profiling of serum using ultra performance liquid chromatography and the LTQ-Orbitrap mass spectrometry system. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2008, 871(2),288-298
115. Waters, N. J.; Waterfield, C. J.; Farrant, R. D.; Holmes, E.; Nicholson, J. K. Metabonomic deconvolution of embedded toxicity:  application to thioacetamide hepato- and nephrotoxicity. Chemical Res. Toxicol, 2005, 18(4), 639-654.
116. Lenz, E. M.; Bright, J.; Knight, R.; Wilson, I. D.; Major, H. Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. J. Pharm. Biomed. Anal, 2004, 35 (3), 599-608.
117. Nicholson, J. K; Connelly, J.; Lindon, J. C; Holmes, E. Me-tabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov., 2002, 1 (2), 153-161.
118. Lenz, E. M.; Bright, J.; Knight, R.; Westwood, F. R.; Davies, D.; Major, H; Wilson, I. D. Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers, 2005, 10(2-3), 173-187.
119. Lenz, E. M.; Bright, J.; Knight, R.; Wilson, I. D.; Major, H. A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: time dependant changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. Analyst, 2004, 129 (6), 535-541.
120. Holmes, E.; Bonner, F. W.; Sweatman, B. C; Lindon, J. C; Bed-dell, C. R.; Rahr, E.; Nicholson, J. K. Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine. Mol Pharmacol, 1992, 42(5), 922-930.
121. Williams, R. E.; Lock, E. A. Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat. Toxicology, 2004, 207(1), 35-48.
122. Williams, R. E.; Major, H; Lock, E. A.; Lenz, E. M.; Wilson, I. D. D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach. Toxicology, 2005, 207(2), 179-190.
123. Sieber, M.; Wagner, S.; Rached, E.; Amberg, A.; Mally, A.; Dekant, W. Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery. Chem. Res. Toxicol, 2009, 22(7), 1221-1231.
124. Beckwith-Hall, B. M.; Nicholson, J. K; Nicholls, A. W.; Foxall, P. J.; Lindon, J. C; Connor, S. C; Abdi, M.; Connelly, J.; Holmes, E. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol, 1998, 11(4), 260-72.
125. Nicholls, A. W.; Holmes, E.; Lindon, J. C; Shockcor, J. P.; Far-rant, R. D.; Haselden, J. N; Damment, S. J.; Waterfield, C. J.; Nicholson, J. K. Metabonomic investigations into hydrazine toxicity in the rat. Chem. Res. Toxicol, 2001, 14(8), 975-987.
126. Coen, M.; Lenz, E. M.; Nicholson, J. K; Wilson, I. D.; Pognan, F.; Lindon, J. C. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol, 2003, 16(3), 295-303.
127. Waters, N. J.; Holmes, E.; Williams, A.; Waterfield, J.; Farrant, R. D.; Nicholson, J. K. nmr and pattern recognition studies on the time-related metabolic effects of u-naphthylisothiocyanate on liver, urine, and plasma in the rat:an integrative metabonomic approach. Chem. Res. Toxicol, 2001, 14 (10), 1401-1412.
128. Mortishire-Smith, R. J.; Skiles, G. L.; Lawrence, J. W.; Spence, S.; Nicholls, A. W.; Johnson, B. A.; Nicholson, J. K. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem. Res. Toxicol, 2004, 17(2), 165-173.
129. Lenz, E. M.; Williams, R. E.; Sidaway, J.; Smith, B. W.; Plumb, R. S.; Johnson, K. A.; Rainville, P.; Shockcor, J.; Stumpf, C. L.; Granger, J. H; Wilson, I. D. The application of microbore UPLC/oa-TOF-MS and 1H NMR spectroscopy to the metabonomic analysis of rat urine following the intravenous administration of pravastatin. J.Pharm.Biomed. Anal, 2007, 44 (4), 845-852.
130. Griffin, J. L.; Walker, L. A.; Shore, F. R.; Nicholson, J. K. Metabolic Profiling of Chronic Cadmium Exposure in the Rat. Chem. Res. Toxicol, 2001, 14(10), 1428-1434.
131. Lafaye, A.; Junot, C; Ramounet-Le Gall, B.; Fritsch, P.; Tabet, J. C; Ezan, E. Metabolite profiling in rat urine by liquid chromatog-raphy/electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicity. Rapid. Commun. Mass. Spectrom., 2003, 17 (22), 2541-2549.
132. Chen, M.; Ni, Y.; Duan, H; Qiu, Y.; Guo, C; Jiao, Y.; Shi, H; Su, M.; Jia, W. Mass spectrometry-based metabolic profiling of rat urine associated with general toxicity induced by the multiglyco-side of Tripterygium wilfordii Hook. f Chem. Res. Toxicol, 2008, 21 (2), 288-294.
133. Xie, G.; Zheng, X.; Qi, X.; Cao, Y.; Chi, Y.; Su, M.; Ni, Y.; Qiu, Y.; Liu, Y.; Li, H.; Zhao, A.; Jia, W. Metabonomic evaluation of melamine-induced acute renal toxicity in rats. J. Proteome. Res., 2010, 9 (1), 125-133.
134. Lindon, J. C; Keun, H. C; Ebbels, T. M.; Pearce, J. M.; Holmes, E.; Nicholson, J. K. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics, 2005, 6 (7), 691-699.
135. Gartland, K. P.; Bonner, F. W.; Nicholson, J. K. Investigations into the biochemical effects of region-specific nephrotoxins. Mol Pharmacol, 1989, 35(2), 242-250.
136. Holmes, E.; Bonner, F. W.; Gartland, K. P.; Nicholson, J. K. Proton NMR monitoring of the onset and recovery of experimental renal damage. J. Pharm. Biomed. Anal, 1990, 8 (8-12), 959-962.
137. Gartland, K. P.; Anthony, M. L.; Beddell, C. R.; Lindon, J. C; Nicholson, J. K. Proton NMR studies on the effects of uranyl nitrate on the biochemical composition of rat urine and plasma. J. Pharm. Biomed. Anal, 1990, 8 (8-12), 951-954.
138. Anthony, M. L.; Gartland, K. P.; Beddell, C. R.; Lindon, J. C; Nicholson, J. K. Studies of the biochemical toxicology of uranyl nitrate in the rat. Arch. Toxicol, 1994, 68(1), 43-53.
139. Gartland, K. P.; Eason, C. T.; Wade, K. E.; Bonner, F. W.; Nicholson, J. K. Proton NMR spectroscopy of bile for monitoring the excretion of endogenous and xenobiotic metabolites: application to para-aminophenol. J. Pharm. Biomed. Anal, 1989, 7 (6), 699-707.
140. Foxall, P. J.; Bending, M. R.; Gartland, K. P.; Nicholson, J. K. Acute renal failure following accidental cutaneous absorption of phenol: application of NMR urinalysis to monitor the disease process. Hum. Toxicol, 1989, 8 (6), 491-496.
141. Sanins, S. M.; Nicholson, J. K.; Elcombe, C; Timbrell, J. A. Hepa-totoxin-induced hypertaurinuria: a proton NMR study. Arch. Toxicol, 1990, 64 (5), 407-411.
142. Sanins, S. M.; Timbrell, J. A.; Elcombe, C; Nicholson, J. K. Proton NMR spectroscopic studies on the metabolism and biochemical effects of hydrazine in vivo. Arch. Toxicol, 1992, 66 (7), 489-495.
143. Ebbels, T. M. D.; Keun, H. C; Beckonert, O. P.; Bollard, M. E.; Lindon, J. C; Holmes, E.; Nicholson, J. K. Prediction and Classification of Drug Toxicity Using Probabilistic Modeling of Temporal Metabolic Data:  The Consortium on Metabonomic Toxicology Screening Approach. J. Proteome Res., 2007, 6 (11), 4407-4422.
144. Ebbels, T.; Keun, H.; Beckonert, O.; Antti, H.; Bollard, M.; Holmes, E.; Lindon, J.; Nicholson, J. Toxicity classification from metabonomic data using a density superposition approach: 'CLOUDS'. Anal. Chim. Acta, 2003, 490 (1-2), 109-122.
145. Keun, H. C; Ebbels, T. M. D.; Bollard, M. E.; Beckonert, O.; Antti, H.; Holmes, E.; Lindon, J. C; Nicholson, J. K. Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. Chem. Res. Toxicol, 2004, 17(5), 579-587.
146. Coen, M.; Want, E. J.; Clayton, T. A.; Rhode, C. M.; Hong, Y. S.; Keun, H. C; Cantor, G. H.; Metz, A. L.; Robertson, D. G.; Reily, M. D.; Holmes, E.; Lindon, J. C; Nicholson, J. K. Mechanistic aspects and novel biomarkers of responder and non-responder pheno-types in galactosamine-induced hepatitis. J. Proteome Res., 2009, 8 (11), 5175-5187.
147. Holmes, E.; Loo, R. L.; Cloarec, O.; Coen, M.; Tang, H.; Mai-baum, E.; Bruce, S.; Chan, Q.; Elliott, P.; Stamler, J.; Wilson, I. D.; Lindon, J. C; Nicholson, J. K. Detection of Urinary Drug Metabolite (Xenometabolome) Signatures in Molecular Epidemiology Studies via Statistical Total Correlation (NMR) Spectroscopy. Anal. Chem., 2007, 79(7), 2629-2640.
148. Holmes, E.; Cloarec, O.; Nicholson, J. K. Probing latent biomarker signatures and in vivo pathway activity in experimental disease states via statistical total correlation spectroscopy (STOCSY) of Biofluids:  application to HgCl2 toxicity. J. Proteome Res., 2006, 5 (6), 1313-1320.
149. Coen, M. A metabonomic approach for mechanistic exploration of pre-clinical toxicology. Toxicology,2010, 278(3),326-340
150. Sands, C. J.; Coen, M.; Maher, A. D.; Ebbels, T. M. D.; Holmes, E.; Lindon, J. C; Nicholson, J. K. Statistical total correlation spectroscopy editing of 1H NMR spectra of biofluids: application to drug metabolite profile identification and enhanced information recovery. Anal Chem., 2009, 81(15), 6458-6466.
151. Robinette, S. L.; Veselkov, K. A.; Bohus, E.; Coen, M.; Keun, H. C; Ebbels, T. M. D.; Beckonert, O.; Holmes, E. C; Lindon, J. C; Nicholson, J. K. Cluster analysis statistical spectroscopy using nuclear magnetic resonance generated metabolic data sets from perturbed biological systems. Anal Chem., 2009, 81(16), 6581-6589.
152. Crockford, D. J.; Holmes, E.; Lindon, J. C; Plumb, R. S.; Zirah, S.; Bruce, S. J.; Rainville, P.; Stumpf, C. L.; Nicholson, J. K. Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal Chem., 2006, 78 (2), 363-71.
153. John, C. L.; Elaine, H.; Jeremy, K. N. Metabonomics in pharmaceutical R & D. FEBS J., 2007, 274(5), 1140-1151.
154. Zhang, B. L. Compound danshen's effective material and mechanism of action. World Sci. Technol: Mod. Tradit. Chin. Med. Mater. Med., 2003, 5, 14-17.
155. Lv, Y.; Liu, X.; Yan, S.; Liang, X.; Yang, Y.; Dai, W.; Zhang, W. Metabolomic study of myocardial ischemia and intervention effects of Compound danshen tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J. Pharm., Biomed., Anal, 2010, 52, (1), 129-135.
156. Dai, Y.; Li, Z.; Xue, L.; Dou, C; Zhou, Y.; Zhang, L.; Qin, X. Metabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress. J. Ethnopharmacol, 2010, 128(2), 482-489.
157. Phapale, P. B.; Kim, S. D.; Lee, H. W.; Lim, M.; Kale, D. D.; Kim, Y. L.; Cho, J. H.; Hwang, D.; Yoon, Y. R. An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus. Clin. Pharmacol. Ther., 2010, 87 (4), 426-436.
158. Sussulini, A.; Prando, A.; Maretto, D. A.; Poppi, R. J.; Tasic, L.; Banzato, C. U. E. M.; Arruda, M. A. l. Z. Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics. Anal. Chem., 2009, 81(23), 9755-9763.
159. Kaddurah-Daouk, R.; McEvoy, J.; Baillie, R. A.; Lee, D.; Yao, J. K.; Doraiswamy, P. M.; Krishnan, K. R. R. Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry, 2007, 12(10), 934-945.
160. Huo, T.; Cai, S.; Lu, X.; Sha, Y.; Yu, M.; Li, F. Metabonomic study of biochemical changes in the serum of type 2 diabetes melli-tus patients after the treatment of metformin hydrochloride. J. Pharm. Biomed. Anal, 2009, 49(4), 976-982.
161. Martijn van, D.; Jack, V.; Albert, T.; Ewoud Jan van, H.; Jacobus, B.; Adam, C; Jan van der, G. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Brt. J. Clin. Pharmacol, 2007, 63(5), 562-574.
162. Sun, J.; Von Tungeln, L. S.; Hines, W.; Beger, R. D. Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis. J. Chromatogr. B, 2009, 877(24), 2557-2565.
163. Wishart, D. S. Metabolomics in monitoring kidney transplants. Curr. Opin. Nephrol. Hypertension, 2006, 15(6), 637-642.
164. Chung, Y. L.; Griffiths, J. R. Using metabolomics to monitor anticancer drugs. In Oncogenes Meet Metabol, 2008, pp 55-78.
165. Gibney, M. J.; Walsh, M.; Brennan, L.; Roche, H. M.; German, B.; van Ommen, B. Metabolomics in human nutrition: opportunities and challenges. Am. J. Clin. Nutr., 2005, 82(3), 497-503.
166. Claudine, M.; Jane, H.; Rafael, L.; Augustin, S. The complex links between dietary phytochemicals and human health deciphered by metabolomics. Mol Nutr. Food Res., 2009, 53(10), 1303-1315.
167. Martin, F.-P. J.; Rezzi, S.; PereÌ-Trepat, E.; Kamlage, B.; Collino, S.; Leibold, E.; Kastler, J. r.; Rein, D.; Fay, L. B.; Kochhar, S. Metabolic Effects of Dark Chocolate Consumption on Energy, Gut Microbiota, and Stress-Related Metabolism in Free-Living Subjects. J. Proteome Res., 2009, 8 (12), 5568-5579.
168. Nicholson, J. K. Use of Metabolomics to Study Gut Microorganisms. Ann. Rev. Nutr., 2009. [Epub ahead of print]
169. Wikoff, W. R.; Anfora, A. T.; Liu, J.; Schultz, P. G.; Lesley, S. A.; Peters, E. C; Siuzdak, G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA, 2009, 106 (10), 3698-3703.
170. Um, S. Y.; Chung, M. W.; Kim, K.-B.; Kim, S. H.; Oh, J. S.; Oh, H. Y.; Lee, H. J.; Choi, K. H. Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats. Anal Chem., 2009, 81(12), 4734-4741.
171. Liu, Y.; Huang, R.; Liu, L.; Peng, J.; Xiao, B.; Yang, J.; Miao, Z.; Huang, H. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using 1H NMR spectroscopy. J. Pharm. Biomed. Anal, 2010, 52 (1), 136-141.
172. Kumar, B. S.; Lee, Y.-J.; Yi, H. J.; Chung, B. C; Jung, B. H. Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach. Anal Chim. Acta, 2010, 661(1), 47-59.
173. Zhang, H.; Patrone, L.; Kozlosky, J.; Tomlinson, L.; Cosma, G.; Horvath, J. Pooled sample strategy in conjunction with high-resolution liquid chromatographyâˆ'mass spectrometry-based background subtraction to identify toxicological markers in dogs treated with ibipinabant. Anal Chem., 2010, 82(9),3834-3839.
174. McCredie, J. Thalidomide and congenital charcot's joints. Lancet, 1973, 302(7837), 1058-1061.
175. West, P. R.; Weir, A. M.; Smith, A. M.; Donley, E. L. R.; Cezar, G. G. Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicol Appl Pharmacol, 2010, 247(1),18-27
176. Clayton, T. A.; Lindon, J. C.; Cloarec, O.; Antti, H.; Charuel, C.; Hanton, G.; Provost, J. P.; Le Net, J. L.; Baker, D.; Walley, R. J.; Everett, J. R.; Nicholson, J. K. Pharmaco-metabonomic phenotyp-ing and personalized drug treatment. Nature, 2006, 440, 1073-1077.
177. Clayton, T. A.; Baker, D.; Lindon, J. C.; Everett, J. R.; Nicholson, J. K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. USA, 2009, 106(34), 14728-14733.
178. Winnike, J. H.; Li, Z.; Wright, F. A.; Macdonald, J. M.; O'Connell, T. M.; Watkins, P. B. Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin. Pharmacol. Ther., 88(1), 45-51.
179. Li, H.; Ni, Y.; Su, M.; Qiu, Y.; Zhou, M.; Qiu, M.; Zhao, A.; Zhao, L.; Jia, W. Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats. J. Proteome Res., 2007, 6(4), 1364-1370.